European Vaccine Initiative, a non-profit organization with decades´ long international vaccine development and project management experience serves as SHIGETECVAX project coordinator. Since 1998 EVI supports the development of effective, accessible, and affordable vaccines for global health. Through promoting innovative solutions for disease control involving their global network of partners, EVI is striving for a world free of the intolerable burden of diseases of poverty within the coming decades. Since its inception in 1998 EVI has contributed to the development and clinical assessment of nearly 40 different vaccine preparations. EVI operates with support from the European Commission, the European & Developing Countries Clinical Trials Partnership (EDCTP), the Innovative Medicines Initiative (IMI), the Global Health Innovative Technology Fund (GHIT), the Coalition for Epidemic Preparedness Innovations (CEPI) and others. EVI is hosted by Heidelberg University in Germany.